Persistence of cardiovascular risk after rof... [Arch Intern Med. 2010] - PubMed

loading

[Assessment and truth -- how many cardio- and cerebrovascular events are in fact to be led back to taking rofecoxib]. [Med Klin (Munich). 2006]
[Assessment and truth -- how many cardio- and cerebrovascular events are in fact to be led back to taking rofecoxib].
Mühlbauer B, Timm J. Med Klin (Munich). 2006 Aug 15; 101(8):673-5; author reply 678-9.
[How many harmed by rofecoxib in Germany?]. [Med Klin (Munich). 2006]
[How many harmed by rofecoxib in Germany?].
Scharnetzky E, Andersohn F, Schill W, Garbe E, Pigeot I. Med Klin (Munich). 2006 Aug 15; 101(8):675-6; author reply 678-9.
Review [Are there any differences in the cardiovascular tolerance between classical NSAIDs and coxibs?]. [Presse Med. 2006]
Review [Are there any differences in the cardiovascular tolerance between classical NSAIDs and coxibs?].
Valat JP, Deray G, Héloire F. Presse Med. 2006 Sep; 35(9 Spec No 1):1S25-34.
Cardiac risks with COX-2 inhibitors. [CMAJ. 2007]
Cardiac risks with COX-2 inhibitors.
Ashworth AJ. CMAJ. 2007 Feb 13; 176(4):489-92.
Review [What do we know about the cardiovascular toxicity of the NSAIDs?]. [Presse Med. 2006]
Review [What do we know about the cardiovascular toxicity of the NSAIDs?].
Sibilia J, Deray G, Montalescot G. Presse Med. 2006 Sep; 35(9 Spec No 1):1S11-23.

Cause-specific cardiovascular risk associated with nonsteroidal anti-inflammatory drugs among myocardial infarction patients--a nationwide study. [PLoS One. 2013]
Cause-specific cardiovascular risk associated with nonsteroidal anti-inflammatory drugs among myocardial infarction patients--a nationwide study.
Olsen AM, Fosbøl EL, Lindhardsen J, Andersson C, Folke F, Nielsen MB, Køber L, Hansen PR, Torp-Pedersen C, Gislason GH. PLoS One. 2013; 8(1):e54309. Epub 2013 Jan 30.

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
References for this PMC Article
Citation referenced in PubMed article. Only valid for PubMed citations that are also in PMC.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Free in PMC
Free full text articles in PMC
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Persistence of cardiovascular risk after rofecoxib discontinuation.
Persistence of cardiovascular risk after rofecoxib discontinuation.
Arch Intern Med. 2010 Dec 13 ;170(22):2035-6. doi: 10.1001/archinternmed.2010.461.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

PubMed